Do you want to read an article? Please log in or register.
Efficacy and safety of brolucizumab every 6 weeks induction therapy for neovascular age-related macular degeneration
Macular Diseases
Related content
Macular Diseases
TALON Phase IIIb Study: 32 Week Primary Results of Brolucizumab Using Treat and Extend for Neovascular Age Related Macular Degeneration
Ophthalmol Retina
Regillo C, Kaiser PK, Kertes PJ, Gillies M, Maio-Twofoot T, D'Souza D, Guenther S, Lawrence D, Holz FG
doi: 10.1016/j.oret.2025.05.030
Macular Diseases
Efficacy and Safety of Ranibizumab Biosimilar QL1205 in Neovascular Age-related Macular Degeneration: A Phase 3 Randomized Trial
Ophthalmol Retina
Hamouz J, Nowosielska A, Święch-Zubilewicz A, Abengoechea S, Baumane K, Vajas A, Siewierska M, Veselovsky M, Veith M, Kerényi Á, Mange S, Baidya K, Laganovska G, Jürgens I, Papp A, Gosai J, Štefanickova J, Han M, Fryczkowski P, Zalewski D, Wang J, Wei W
doi: 10.1016/j.oret.2024.10.001
Macular Diseases
Comparative efficacy of intravitreal anti-VEGF therapy for neovascular age-related macular degeneration: A systematic review with network meta-analysis
Acta Ophthalmol
Butler ETS, Arnold-Vangsted A, Schou MG, Anguita R, Bjerager J, Borrelli E, Cehofski LJ, Ferro Desideri L, van Dijk EHC, Faber C, Grauslund J, Hajari JN, Huemer J, Klefter ON, Krogh Nielsen M, Sabaner MC, Schneider M, Subhi Y
doi: 10.1111/aos.17506
Macular Diseases
MERLIN: Two-Year Results of Brolucizumab in Participants With Neovascular Age-Related Macular Degeneration and Persistent Retinal Fluid
Ophthalmology
Brown DM, Jaffe GJ, Wykoff CC, Adiguzel E, Heier JS, Khanani AM
doi: 10.1016/j.ophtha.2024.08.022
Macular Diseases
Outlier ophthalmologists in the treatment of neovascular age-related macular degeneration with intravitreal therapy
Br J Ophthalmol
Hashimoto Y, Hunt AR, Wells JM, Banerjee G, Ferrier R, Barry R, Field A, Game J, Hooper CY, Barthelmes D, Gillies MC
doi: 10.1136/bjo-2024-326024
Macular Diseases
Real-World 10-Year Outcomes of Anti-VEGF Therapy for Neovascular Age-Related Macular Degeneration: A Meta-Analysis
Clin Exp Ophthalmol
Spooner K, Broadhead G, Fraser-Bell S, Hong T, Wong JG, Chang AA
doi: 10.1111/ceo.14559
RECOMMENDED
Macular Diseases
Macular Atrophy in Neovascular Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis
★ 3
Recommended by
Prof. emer. Dr Josef Flammer, Faculty Member
Ophthalmol Retina
Berni A, Coletto A, Li J, Shen M, Bandello F, Reibaldi M, Borrelli E
doi: 10.1016/j.oret.2025.01.011
Macular DiseasesFurther Publications
Subretinal fibrosis occurrence according to macular neovascularisation subtypes in neovascular age-related macular degeneration
Acta Ophthalmol
Lenhof S, Kodjikian L, Gascon P, Gadiollet E, Feldman A, De Bats F, Wolff B, Pradat P, Mathis T
doi: 10.1111/aos.16759
Macular Diseases
Impact of Duration of Exposure to Intraretinal Fluid on Visual Outcomes in Neovascular Age-Related Macular Degeneration
Ophthalmol Retina
Steinle NC, McCullough AJ, Silva FQ, Du W, Moini H, Singh RP
doi: 10.1016/j.oret.2024.12.018